Author:
Al-Sarraj Mariam,Burns Megan,Patel Vinod
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Scottish Dental Clinical Effectiveness Programme. Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw. 2017. Available at https://www.sdcep.org.uk/published-guidance/medication-related-osteonecrosis-of-the-jaw/ (accessed October 2023).
2. Coleman R, Body J J, Aapro M, Hadji P, Herrstedt J. Bone health in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol 2014; 25: 124-137.
3. Ruggiero S L, Dodson T B, Aghaloo T, Carlson E R, Ward B B, Kademani D. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws - 2022 Update. J Oral Maxillofac Surg 2022; 80: 920-943.
4. Bhula S, Mallya S, Tetradis S. The role of imaging in MRONJ: An evidence based, institutional experience. Oral Surg Oral Med Oral Pathol Oral Radiol 2020; 130: 58-59.
5. Marx R E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115-1117.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献